Answers are grounded in this paper and cite their sources.
The latest class of neuroendovascular devices being evaluated is intended to treat cerebral aneurysms. In addition to inducing flow stasis-mediated thrombosis of aneurysms and thus at times being referred to as flow diverters, these devices reconstitute pathologic arterial segments to near-physiologic normalcy. The successful implementation of such an endoluminal scaffold for vascular reconstruction in the cerebral circulation requires careful consideration of various factors drawn from engineering, physics, and biological sciences. Here we review some of these factors.
No takes yet. Share an insight, caveat, or question.
Lieber et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: